Literature DB >> 2580543

Use of flupirtine maleate as an analgesic in patients with liver disease.

P Powell-Jackson, R Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2580543

Source DB:  PubMed          Journal:  Br J Clin Pract        ISSN： 0007-0947


× No keyword cloud information.
  8 in total

1.  Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years.

Authors:  Martin C Michel; Piotr Radziszewski; Christian Falconer; Daniela Marschall-Kehrel; Koenraad Blot
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

2.  Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1.

Authors:  Werner Siegmund; Christiane Modess; Eberhard Scheuch; Karen Methling; Markus Keiser; Ali Nassif; Dieter Rosskopf; Patrick J Bednarski; Jürgen Borlak; Bernd Terhaag
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

Review 3.  Flupirtine in pain management: pharmacological properties and clinical use.

Authors:  Jacques Devulder
Journal:  CNS Drugs       Date:  2010-10       Impact factor: 5.749

4.  Pathology of flupirtine-induced liver injury: a histological and clinical study of six cases.

Authors:  Florian Puls; Clemens Agne; Fritz Klein; Martin Koch; Kinan Rifai; Michael P Manns; Jürgen Borlak; Hans H Kreipe
Journal:  Virchows Arch       Date:  2011-05-18       Impact factor: 4.064

Review 5.  Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states.

Authors:  H A Friedel; A Fitton
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

6.  Dose-related analgesic effects of flupirtine.

Authors:  T Hummel; T Friedmann; E Pauli; G Niebch; H O Borbe; G Kobal
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

7.  Correlation versus causation? Pharmacovigilance of the analgesic flupirtine exemplifies the need for refined spontaneous ADR reporting.

Authors:  Nora Anderson; Juergen Borlak
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

8.  Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery.

Authors:  Valentina Peta; Chantal Tse; Hugo Perazzo; Mona Munteanu; Yen Ngo; An Ngo; Nittia Ramanujam; Lea Verglas; Maxime Mallet; Vlad Ratziu; Dominique Thabut; Marika Rudler; Vincent Thibault; Ina Schuppe-Koistinen; Dominique Bonnefont-Rousselot; Bernard Hainque; Françoise Imbert-Bismut; Michael Merz; Gerd Kullak-Ublick; Raul Andrade; Florian van Boemmel; Eckart Schott; Thierry Poynard
Journal:  PLoS One       Date:  2017-12-29       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.